Sorrento’s vaccine shows promise against coronavirus, variants in animal studies
The sera of vaccinated mice showed neutralisation of infection caused by the original coronavirus and major variants of concern…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sorrento Therapeutics
Sorrento gets US FDA nod for Phase 1 clinical trial of neutralising antibody in COVID-19 patients
Sorrento had earlier informed that COVI-GUARD (STI-1499) demonstrated 100 per cent in vitro neutralizing effect against SARS-CoV-2…
Cancer CART therapy: What are the benefits and stakes?
Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…